Bridgeway Capital Management »

Acrivon Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $337k 58k 5.80
2024-03-31 $416k 58k 7.15